Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Unraveling TP53 -Mutated Acute Myeloid Leukemia : Clinical Insights and Genetic Profiles

Songyi Park, Sang-A Kim, Ji Yun Lee, Ja Min Byun, Jeong-Ok Lee, Youngil Koh, Junshik Hong, Junglim Lee, Soo-Mee Bang, Inho Kim, Sung-Soo Yoon, Dongyeop Shin

Blood (2024) 144 (Supplement 1): 5944.

https://doi.org/10.1182/blood-2024-202293

Published: 2024

Journal Articles

Ropeginterferon in Low-Risk Patients with Polycythemia Vera

Ji Yun Lee, Sung-Eun Lee, Sung-Soo Yoon, Deok-Hwan Yang, Sang Kyun Sohn, Seug Yun Yoon, Soo-Mee Bang, Gyeong Won Lee, Chul Won Choi, Yunsuk Choi, June-Won Cheong, Young Hoon Park

Blood (2024) 144 (Supplement 1): 1799.

https://doi.org/10.1182/blood-2024-202345

Published: 2024

Journal Articles

Real-World Efficacy and Safety of Teclistamab for Patients with Released or Refractory Multiple Myeloma: Korean, Nationwide, Retrospective Analysis of an Named Patient Program

Jun Ho Yi, Jae Hoon Lee, Sung-Hoon Jung, Ji Hyun Lee, Ji Yun Lee, Kihyun Kim, Sung-Soo Park, Chang-Ki Min, Yoon Seok Choi, Min Kyoung Kim, Ho-Young Yhim, Dok Hyun Yoon

Blood (2024) 144 (Supplement 1): 7033.

https://doi.org/10.1182/blood-2024-207611

Published: 2024

Journal Articles

Multicenter, Open-Label Phase 1/2a Study of Pxs-5505 and Ruxolitinib in Patients with Primary, Post-Polycythemia Vera (PV) or Post-Essential Thrombocythemia (ET) Myelofibrosis

Peter Tan, Ross Baker, Sung-Eun Lee, Anne Marie Watson, Stanley Cheung, Shang-Ju Wu, Chih-Cheng Chen, Shuhying Tan, Pankit Vachhani, Tsai-Yun Chen, Jae Hoon Lee, Hui-Hua Hsiao, Ji Yun Lee, Won Sik Lee, Lucia Masarova, Jana Baskar, Wolfgang Jarolimek, Joanna Leadbetter

Blood (2024) 144 (Supplement 1): 1001.

https://doi.org/10.1182/blood-2024-204290

Published: 2024

Journal Articles

Real-World Efficacy and Safety of Letermovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Analysis at a Single Center

Sang-A Kim, Ji Yun Lee, Soo-Mee Bang, Jeong-Ok Lee

Blood (2023) 142 (Supplement 1): 6970.

https://doi.org/10.1182/blood-2023-188410

Published: 2023

Journal Articles

A Multicenter Prospective Study for Validation of the Korean Simple Geriatric Assessment Tool in Elderly Patients with Multiple Myeloma

Ji Yun Lee, Soo-Mee Bang, Sang-A Kim, Youngil Koh, Ho-Young Yhim, Lee Gyeong-Won, Chang-Ki Min, Young Rok Do, Hyo Jung Kim, Sung Hwa Bae, Hyeon-Seok Eom, Je-Jung Lee, Hyunkyung Park, Seung-Hyun Nam, Ji Hyun Lee, Sung-Hyun Kim, Hyun Jung Lee, Min Kyoung Kim

Blood (2022) 140 (Supplement 1): 12501–12502.

https://doi.org/10.1182/blood-2022-165807

Published: 2022

Journal Articles

Preliminary Result of a Pilot Study of Apixaban in the Treatment of Splanchnic Vein Thrombosis

Sang-A Kim, Ji Yun Lee, Jeong-Ok Lee, Soo-Mee Bang

Blood (2022) 140 (Supplement 1): 5678–5679.

https://doi.org/10.1182/blood-2022-168446

Published: 2022

Journal Articles

Incidence of Skeletal-Related Events Among Multiple Myeloma Patients: A Nationwide Population-Based Cohort Study

Ji Yun Lee, Ju Hyun Lee, Sang-A Kim, Koung Jin Suh, Ji-Won Kim, Se Hyun Kim, Jeong-Ok Lee, Jin Won Kim, Yu Jung Kim, Keun-Wook Lee, Jee Hyun Kim, Jong-Seok Lee, Soo-Mee Bang, Eun Hee Jung, Minsu Kang

Blood (2022) 140 (Supplement 1): 12570.

https://doi.org/10.1182/blood-2022-168747

Published: 2022

Journal Articles

A Nationwide Epidemiologic Study for Disease Transformation and Secondary Cancers in Korean Patients with Myeloproliferative Neoplasms

Junshik Hong, MD, Ju Hyun Lee, Ja Min Byun, MD, Ji Yun Lee, MD, Hyun Jung Lee, MD, Sang Mee Hwang, MD PhD, Byung-Su Kim, MD PhD, Hyo Jung Kim, MD PhD, Jung Lim Lee, MD, Dong-Yeop Shin, MD PhD, Youngil Koh, MD PhD, Sung-Soo Yoon, MD PhD, Soo-Mee Bang, MD PhD

Blood (2018) 132 (Supplement 1): 4314.

https://doi.org/10.1182/blood-2018-99-116298

Published: 2018

Journal Articles

Therapy-Related Myeloid Neoplasms Are Not Always Dismal If They Have Better Cytogenetic Profile and Longer Latency Period from Preceding Anti-Cancer Treatment

Junshik Hong, MD, Ji Yun Lee, MD, Ja Min Byun, MD, Dong-Yeop Shin, MDPhD, Youngil Koh, MD, Inho Kim, MD PhD, Sung-Soo Yoon, MD PhD

Blood (2017) 130 (Supplement 1): 1307.

https://doi.org/10.1182/blood.V130.Suppl_1.1307.1307

Published: 2017

Journal Articles

Clinical Dissection of Infectious Event Following ATG Treatment for Aplastic Anemia and Hypoplastic Myelodysplastic Syndrome Reveals Urgent Need for Anti-Aspergillus Prophylaxis

Hee-Ryeong Jang, MD, Sung-Soo Yoon, MD PhD, Inho Kim, MD PhD, Soo-Mee Bang, MD PhD, Junshik Hong, MD, Dong-Yeop Shin, MDPhD, Ji Yun Lee, MD, Jeong-Ok Lee, MD, Byung-Su Kim, MD PhD, Hyo Jung Kim, MD PhD, Wan Beom Park, MD PhD, Nam Joong Kim, MD PhD, Youngil Koh, MD

Blood (2017) 130 (Supplement 1): 2463.

https://doi.org/10.1182/blood.V130.Suppl_1.2463.2463

Published: 2017

Journal Articles

Incidence of Venous Thromboembolism in Korea from 2009 to 2013

Junshik Hong, MD, Ji Yun Lee, MD, Ju Hyun Lee, Ho-Young Yhim, MD, Won-Il Choi, Soo-Mee Bang, MD PhD, Heeyoung Lee, Doyeun Oh, MD

Blood (2017) 130 (Supplement 1): 3703.

https://doi.org/10.1182/blood.V130.Suppl_1.3703.3703

Published: 2017

Journal Articles

Bleeding Complications in CAT Patients Treated with LMWH or DOACs

Kyoung Ha Kim, Ho-Young Yhim, MD, Won-Il Choi, Sung-Hyun Kim, MD PhD, Yeung-Chul Mun, MD PhD, Soo-Mee Bang, MD PhD, Doyeun Oh, MD, Ji Hyun Lee, MD PhD, Ji Yun Lee, MD

Blood (2017) 130 (Supplement 1): 4914.

https://doi.org/10.1182/blood.V130.Suppl_1.4914.4914

Published: 2017

Journal Articles

Analysis of Adverse Events of Dasatinib and Nilotinib in Chronic Phase Chronic Myeloid Leukemia Patients Treated Outside Clinical Trials

Koung Jin Suh, Ji Yun Lee, Dong-Yeop Shin, MD PhD, Youngil Koh, MD PhD, Soo-Mee Bang, Sung-Soo Yoon, MD PhD, Seonyang Park, Inho Kim, Jeong-Ok Lee

Blood (2016) 128 (22): 1902.

https://doi.org/10.1182/blood.V128.22.1902.1902

Published: 2016

Journal Articles

Epidemiology and Management of Immune Thrombocytopenia: A Nationwide Population-Based Study in Korea

Ji Yun Lee, Ju Hyun Lee, Jung-Ok Lee, Soo-Mee Bang

Blood (2016) 128 (22): 4934.

https://doi.org/10.1182/blood.V128.22.4934.4934

Published: 2016

Journal Articles

Bortezomib Based Induction Is Superior to Thalidomide Based Induction in Reducing Early Relapses Following Upfront HDM: an Analysis By the Asian Myeloma Working Group

Sathish Kumar Gopalakrishnan, FRCPath, Shin-Yeu Ong, MD MRCP, MSE, Seok Jin Kim, Hae Su Kim, MD, Ji Yun Lee, Sung Hee Lim, Yunxin Chen, MBBS, MRCP, FRCPath, Sanjay De Mel, BSc, FRCPath, MRCP,, Melissa G. Ooi, Shilpa Surendran, MBBS, Adeline Lin, Daryl Tan, MBBS, MRCP, Brian G M Durie, Wee Joo Chng, MB ChB, MRCP, PhD, Kihyun Kim, MD PhD

Blood (2016) 128 (22): 4650.

https://doi.org/10.1182/blood.V128.22.4650.4650

Published: 2016

Journal Articles

Clinical Relevance of Failure to Achieve Early Molecular Response in Chronic Myeloid Leukemia in Chronic Phase

Ji Yun Lee, Sung Hee Lim, Hae Su Kim, Kwai Han Yoo, Haa-Na Song, Jinhyun Cho, Silvia Park, Seok Jin Kim, Won Seog Kim, Kihyun Kim, Jun Ho Jang, Chul Won Jung

Blood (2015) 126 (23): 5160.

https://doi.org/10.1182/blood.V126.23.5160.5160

Published: 2015

Journal Articles

Non Malignant Late Complications After Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT); Korean Experience

Silvia Park, Su Jin Lee, Won jin Chang, Chi Hoon Maeng, Jung Yong Hong, Moon Ki Choi, Sung Hee Lim, Ji Yun Lee, Chul Won Jung, Jun Ho Jang, MD, PhD, Kihyun Kim, Young Saing Kim, Je-Hwan Lee, MD, PhD, Sung-Soo Yoon, MD, PhD

Blood (2012) 120 (21): 4462.

https://doi.org/10.1182/blood.V120.21.4462.4462

Published: 2012

Journal Articles

Comparison of BuCy (Busulfan plus Cyclophosphamide) Versus FluBu4 (Fludarabine plus Busulfan) As a Conditioning Regimen for Allogeneic Stem Cell Transplantation

Silvia Park, Jung Yong Hong, Moon Ki Choi, Young Saing Kim, Ji Yun Lee, Sung Hee Lim, Chul Won Jung, Jun Ho Jang, MD, PhD, Kihyun Kim

Blood (2012) 120 (21): 4522.

https://doi.org/10.1182/blood.V120.21.4522.4522

Published: 2012

NARROW

Unraveling TP53 -Mutated Acute Myeloid Leukemia : Clinical Insights and Genetic Profiles

Ropeginterferon in Low-Risk Patients with Polycythemia Vera

Real-World Efficacy and Safety of Teclistamab for Patients with Released or Refractory Multiple Myeloma: Korean, Nationwide, Retrospective Analysis of an Named Patient Program

Multicenter, Open-Label Phase 1/2a Study of Pxs-5505 and Ruxolitinib in Patients with Primary, Post-Polycythemia Vera (PV) or Post-Essential Thrombocythemia (ET) Myelofibrosis

Real-World Efficacy and Safety of Letermovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Analysis at a Single Center

A Multicenter Prospective Study for Validation of the Korean Simple Geriatric Assessment Tool in Elderly Patients with Multiple Myeloma

Preliminary Result of a Pilot Study of Apixaban in the Treatment of Splanchnic Vein Thrombosis

Incidence of Skeletal-Related Events Among Multiple Myeloma Patients: A Nationwide Population-Based Cohort Study

A Nationwide Epidemiologic Study for Disease Transformation and Secondary Cancers in Korean Patients with Myeloproliferative Neoplasms

Therapy-Related Myeloid Neoplasms Are Not Always Dismal If They Have Better Cytogenetic Profile and Longer Latency Period from Preceding Anti-Cancer Treatment

Clinical Dissection of Infectious Event Following ATG Treatment for Aplastic Anemia and Hypoplastic Myelodysplastic Syndrome Reveals Urgent Need for Anti-Aspergillus Prophylaxis

Incidence of Venous Thromboembolism in Korea from 2009 to 2013

Bleeding Complications in CAT Patients Treated with LMWH or DOACs

Analysis of Adverse Events of Dasatinib and Nilotinib in Chronic Phase Chronic Myeloid Leukemia Patients Treated Outside Clinical Trials

Epidemiology and Management of Immune Thrombocytopenia: A Nationwide Population-Based Study in Korea

Bortezomib Based Induction Is Superior to Thalidomide Based Induction in Reducing Early Relapses Following Upfront HDM: an Analysis By the Asian Myeloma Working Group

Clinical Relevance of Failure to Achieve Early Molecular Response in Chronic Myeloid Leukemia in Chronic Phase

Non Malignant Late Complications After Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT); Korean Experience

Comparison of BuCy (Busulfan plus Cyclophosphamide) Versus FluBu4 (Fludarabine plus Busulfan) As a Conditioning Regimen for Allogeneic Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only